These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11299061)

  • 1. Superantigen antagonist peptides.
    Llewelyn M; Cohen J
    Crit Care; 2001; 5(2):53-5. PubMed ID: 11299061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.
    Ramachandran G; Tulapurkar ME; Harris KM; Arad G; Shirvan A; Shemesh R; Detolla LJ; Benazzi C; Opal SM; Kaempfer R; Cross AS
    J Infect Dis; 2013 Jun; 207(12):1869-77. PubMed ID: 23493729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide.
    Arad G; Hillman D; Levy R; Kaempfer R
    Immunol Lett; 2004 Feb; 91(2-3):141-5. PubMed ID: 15019282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bacterial superantigen and superantigen-like proteins.
    Fraser JD; Proft T
    Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal Models Used to Study Superantigen-Mediated Diseases.
    Brosnahan AJ
    Methods Mol Biol; 2016; 1396():1-17. PubMed ID: 26676033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defense against biologic warfare with superantigen toxins.
    Kaempfer R; Arad G; Levy R; Hillman D
    Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
    Arad G; Hillman D; Levy R; Kaempfer R
    J Leukoc Biol; 2001 Jun; 69(6):921-7. PubMed ID: 11404377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide antagonists of superantigen toxins.
    Kaempfer R
    Mol Divers; 2004; 8(2):113-20. PubMed ID: 15209162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal and streptococcal superantigen exotoxins.
    Spaulding AR; Salgado-Pabón W; Kohler PL; Horswill AR; Leung DY; Schlievert PM
    Clin Microbiol Rev; 2013 Jul; 26(3):422-47. PubMed ID: 23824366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens.
    Sriskandan S; Faulkner L; Hopkins P
    Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superantigens and pseudosuperantigens of gram-positive cocci.
    Fleischer B; Gerlach D; Fuhrmann A; Schmidt KH
    Med Microbiol Immunol; 1995 May; 184(1):1-8. PubMed ID: 8538573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.
    Roggiani M; Stoehr JA; Olmsted SB; Matsuka YV; Pillai S; Ohlendorf DH; Schlievert PM
    Infect Immun; 2000 Sep; 68(9):5011-7. PubMed ID: 10948118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bacterial superantigens by peptides and antibodies.
    Visvanathan K; Charles A; Bannan J; Pugach P; Kashfi K; Zabriskie JB
    Infect Immun; 2001 Feb; 69(2):875-84. PubMed ID: 11159981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antimicrobial peptides that inhibit gram positive bacterial exotoxin synthesis.
    Merriman JA; Nemeth KA; Schlievert PM
    PLoS One; 2014; 9(4):e95661. PubMed ID: 24748386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of streptococcal and staphylococcal superantigens in septic shock.
    Bannan J; Visvanathan K; Zabriskie JB
    Infect Dis Clin North Am; 1999 Jun; 13(2):387-96, ix. PubMed ID: 10340173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome.
    Sriskandan S; Moyes D; Cohen J
    Lancet; 1996 Nov; 348(9037):1315-6. PubMed ID: 8909404
    [No Abstract]   [Full Text] [Related]  

  • 18. Microbial superantigens as virulence factors and ways to counteract their actions.
    Tarkowski A; Collins LV; Jonsson IM; Eriksson K; Sakiniene E; Verdrengh M
    Scand J Infect Dis; 2003; 35(9):642-6. PubMed ID: 14620148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.
    Brosnahan AJ; Schlievert PM
    FEBS J; 2011 Dec; 278(23):4649-67. PubMed ID: 21535475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to staphylococcal superantigens.
    Krakauer T
    Immunol Res; 1999; 20(2):163-73. PubMed ID: 10580640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.